Webb19 dec. 2006 · CONTACT: GSK Enquiries, UK Media enquiries, Philip Thomson, Gwenan Evans,or Alice Hunt, +44-020-8047-5502, or US & Canada Media enquiries, BrianJones, +1-215-751-3415, or Malesia Dunn, +1-412-200-3544, or Patricia Seif,+1-215-751-7709, or European Analyst-Investor enquiries, Anita Kidgell,+44-020-804-5542, or Jen Hill, +44-020 … WebbView Philip Thomson’s professional profile on LinkedIn. LinkedIn is the world’s largest business network, helping professionals like Philip Thomson discover inside connections to recommended job candidates, industry experts, and business partners.
100+ "Philip Thomson" profiles LinkedIn
Webb7 juli 2024 · The world's largest vaccine-maker GSK has put its vaccine booster technology to work in a potential new COVID-19 shot, to be developed with a Canadian biopharmaceutical company backed by tobacco ... WebbGlaxoSmithKline enquiries UK Media enquiries: Philip Thomson (020) 8047 5502 Claire Brough (020) 8047 5502 Stephen Rea (020) 8047 5502 Alexandra Harrison (020) 8047 … portability of benefits nsnu
Philip C. Thomson Net Worth (2024) wallmine
WebbGSK PLC : Presentatie van het bedrijf GSK PLC, aandeelhouders, management, bedrijfsomschrijving, financiële beoordelingen, officiële persberichten, contactgegevens ... Webb14 sep. 2024 · Philip Thomson President, Global Affairs, GSK Published Sep 14, 2024 + Follow ... Innovation that is accessible is something we strongly believe in at GSK. Phil Thomson President, Global Affairs. Phil is President, Global Affairs at GSK and a member of the GSK Leadership Team. He has specific responsibilities for the Group’s strategic approach to Reputation, Corporate Responsibility, Global Health, Government affairs and external policy. portability money